{"transactions":[{"id":4613510,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":182669,"kind":"person","name":"Ory Daniel Scott","position":1,"cik":"0002149618","reported_name":"Ory Daniel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Stock Option (right to  buy)","published_at":"2026-09-09T20:58:20.000Z","date":"2026-09-08","kind":"grant","planned":false,"acquired":true,"shares":950000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on September 8, 2026 and is scheduled to vest over four years, with 25% of the shares to vest on October 15, 2027 and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through October 15, 2030."}],"balance_after":950000,"derivative":{"exercise_price":3.03,"expiration_date":"2036-09-07","underlying":"Common Stock","underlying_shares":950000},"source":{"system":"sec-edgar","filing":"0002149618-26-000006","document":"wk-form4_1788987497.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2149618/000214961826000006/wk-form4_1788987497.xml","form_type":"4"}},{"id":4541,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10100,"kind":"person","name":"Burkly Linda","position":1,"cik":"0001985604","reported_name":"Burkly Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2026-09-04T20:27:42.000Z","date":"2026-09-03","kind":"sale","planned":true,"acquired":false,"shares":709,"price":3.0372,"value":2153.3748,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 2, 2026. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $3.0050 to $3.0372. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":61660,"source":{"system":"sec-edgar","filing":"0001985604-26-000003","document":"wk-form4_1788553659.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1985604/000198560426000003/wk-form4_1788553659.xml","form_type":"4"}},{"id":4507,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10091,"kind":"person","name":"Parison Amy","position":1,"cik":"0002063082","reported_name":"Parison Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-04T20:25:26.000Z","date":"2026-09-03","kind":"sale","planned":true,"acquired":false,"shares":453,"price":3.0372,"value":1375.8516,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 7, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 2, 2026. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":13839,"source":{"system":"sec-edgar","filing":"0002063082-26-000006","document":"wk-form4_1788553522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2063082/000206308226000006/wk-form4_1788553522.xml","form_type":"4"}},{"id":4500,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10088,"kind":"person","name":"O'Neill Gilmore Neil","position":1,"cik":"0001742084","reported_name":"O'Neill Gilmore Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-09-04T20:22:41.000Z","date":"2026-09-03","kind":"sale","planned":true,"acquired":false,"shares":5124,"price":3.0372,"value":15562.6128,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 13, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 2, 2026. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $3.0050 to $3.0372. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":243189,"source":{"system":"sec-edgar","filing":"0001742084-26-000003","document":"wk-form4_1788553359.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1742084/000174208426000003/wk-form4_1788553359.xml","form_type":"4"}},{"id":692738,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":25337,"kind":"person","name":"Ellinor Patrick Thomas II","position":1,"cik":"0002137699","reported_name":"Ellinor Patrick Thomas II","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to  buy)","published_at":"2026-08-07T21:16:31.000Z","date":"2026-08-06","kind":"grant","planned":false,"acquired":true,"shares":103400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on August 6, 2026 and is scheduled to vest over three years in equal yearly installments of one-third of the shares beginning on August 6, 2027 through August 6, 2029."}],"balance_after":103400,"derivative":{"exercise_price":2.9,"expiration_date":"2036-08-05","underlying":"Common Stock","underlying_shares":103400},"source":{"system":"sec-edgar","filing":"0002137699-26-000004","document":"wk-form4_1786137389.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000213769926000004/wk-form4_1786137389.xml","form_type":"4"}},{"id":695263,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10091,"kind":"person","name":"Parison Amy","position":1,"cik":"0002063082","reported_name":"Parison Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-05T20:07:57.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":678,"price":2.58,"value":1749.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 7, 2022, and represents the sale of shares by the Issuer necessary to meet tax  withholding obligations as a result of vesting in restricted stock units on August 1, 2026. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":14292,"source":{"system":"sec-edgar","filing":"0002063082-26-000003","document":"wk-form4_1785960474.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000206308226000003/wk-form4_1785960474.xml","form_type":"4"}},{"id":701306,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10100,"kind":"person","name":"Burkly Linda","position":1,"cik":"0001985604","reported_name":"Burkly Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2026-07-29T20:51:02.000Z","date":"2026-07-28","kind":"sale","planned":true,"acquired":false,"shares":4928,"price":2.67,"value":13157.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on July 24, 2026. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":62369,"source":{"system":"sec-edgar","filing":"0001650664-26-000076","document":"wk-form4_1785358259.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066426000076/wk-form4_1785358259.xml","form_type":"4"}},{"id":730009,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":24717,"kind":"person","name":"Connaughton Bernadette","position":1,"cik":"0001662521","reported_name":"Connaughton Bernadette","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to  buy)","published_at":"2026-06-22T20:31:17.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":51700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 17, 2026 and is scheduled to vest in full on June 17, 2027."}],"balance_after":51700,"derivative":{"exercise_price":2.55,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":51700},"source":{"system":"sec-edgar","filing":"0001650664-26-000072","document":"wk-form4_1782160274.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066426000072/wk-form4_1782160274.xml","form_type":"4"}},{"id":730012,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to  buy)","published_at":"2026-06-22T20:30:49.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":51700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 17, 2026 and is scheduled to vest in full on June 17, 2027."}],"balance_after":51700,"derivative":{"exercise_price":2.55,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":51700},"source":{"system":"sec-edgar","filing":"0001650664-26-000071","document":"wk-form4_1782160247.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1648715/000165066426000071/wk-form4_1782160247.xml","form_type":"4"}},{"id":730040,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":36225,"kind":"person","name":"Hirsch Andrew","position":1,"cik":"0001586707","reported_name":"Hirsch Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to  buy)","published_at":"2026-06-22T20:30:09.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":51700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 17, 2026 and is scheduled to vest in full on June 17, 2027."}],"balance_after":51700,"derivative":{"exercise_price":2.55,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":51700},"source":{"system":"sec-edgar","filing":"0001650664-26-000070","document":"wk-form4_1782160207.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586707/000165066426000070/wk-form4_1782160207.xml","form_type":"4"}},{"id":730010,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":35959,"kind":"person","name":"Scadden David","position":1,"cik":"0001707715","reported_name":"Scadden David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to  buy)","published_at":"2026-06-22T20:29:33.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":51700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 17, 2026 and is scheduled to vest in full on June 17, 2027."}],"balance_after":51700,"derivative":{"exercise_price":2.55,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":51700},"source":{"system":"sec-edgar","filing":"0001650664-26-000069","document":"wk-form4_1782160170.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066426000069/wk-form4_1782160170.xml","form_type":"4"}},{"id":730646,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":35687,"kind":"person","name":"Levy Elliott M.","position":1,"cik":"0001858745","reported_name":"Levy Elliott M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to  buy)","published_at":"2026-06-22T20:28:57.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":51700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 17, 2026 and is scheduled to vest in full on June 17, 2027."}],"balance_after":51700,"derivative":{"exercise_price":2.55,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":51700},"source":{"system":"sec-edgar","filing":"0001650664-26-000068","document":"wk-form4_1782160133.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858745/000165066426000068/wk-form4_1782160133.xml","form_type":"4"}},{"id":747457,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10091,"kind":"person","name":"Parison Amy","position":1,"cik":"0002063082","reported_name":"Parison Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-05T20:33:31.000Z","date":"2026-06-03","kind":"sale","planned":true,"acquired":false,"shares":464,"price":2.701,"value":1253.264,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 7, 2022, and represents the sale of shares by the Issuer necessary to meet tax\nwithholding obligations as a result of vesting in restricted stock units on June 2, 2026. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $2.7010 to $2.7049. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":14970,"source":{"system":"sec-edgar","filing":"0001650664-26-000057","document":"wk-form4_1780691609.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066426000057/wk-form4_1780691609.xml","form_type":"4"}},{"id":747455,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10088,"kind":"person","name":"O'Neill Gilmore Neil","position":1,"cik":"0001742084","reported_name":"O'Neill Gilmore Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-06-05T20:33:02.000Z","date":"2026-06-03","kind":"sale","planned":true,"acquired":false,"shares":15380,"price":2.7011,"value":41542.918,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 13, 2022, and represents the sale of shares by the Issuer necessary to meet tax\nwithholding obligations as a result of vesting in restricted stock units on June 2, 2026. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $2.7010 to $2.7250. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":248313,"source":{"system":"sec-edgar","filing":"0001650664-26-000056","document":"wk-form4_1780691579.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066426000056/wk-form4_1780691579.xml","form_type":"4"}},{"id":747456,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10100,"kind":"person","name":"Burkly Linda","position":1,"cik":"0001985604","reported_name":"Burkly Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2026-06-05T20:32:35.000Z","date":"2026-06-03","kind":"sale","planned":true,"acquired":false,"shares":731,"price":2.7011,"value":1974.5041,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax\nwithholding obligations as a result of vesting in restricted stock units on June 2, 2026. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $2.7010 to $2.7050.  The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":67297,"source":{"system":"sec-edgar","filing":"0001650664-26-000055","document":"wk-form4_1780691552.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066426000055/wk-form4_1780691552.xml","form_type":"4"}},{"id":841089,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10088,"kind":"person","name":"O'Neill Gilmore Neil","position":1,"cik":"0001742084","reported_name":"O'Neill Gilmore Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (right to  buy)","published_at":"2026-03-16T20:37:09.000Z","date":"2026-03-12","kind":"grant","planned":true,"acquired":true,"shares":1015200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on March 12, 2026 and is scheduled to vest over four years in equal monthly installments beginning on April 12, 2026 through March 12, 2030."}],"balance_after":1015200,"derivative":{"exercise_price":2.54,"expiration_date":"2036-03-11","underlying":"Common Stock","underlying_shares":1015200},"source":{"system":"sec-edgar","filing":"0001650664-26-000023","document":"wk-form4_1773693426.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066426000023/wk-form4_1773693426.xml","form_type":"4"}},{"id":841088,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10091,"kind":"person","name":"Parison Amy","position":1,"cik":"0002063082","reported_name":"Parison Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Stock Option (right to  buy)","published_at":"2026-03-16T20:35:51.000Z","date":"2026-03-12","kind":"grant","planned":true,"acquired":true,"shares":292856,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on March 12, 2026 and is scheduled to vest over four years in equal monthly installments beginning on April 12, 2026 through March 12, 2030."}],"balance_after":292856,"derivative":{"exercise_price":2.54,"expiration_date":"2036-03-11","underlying":"Common Stock","underlying_shares":292856},"source":{"system":"sec-edgar","filing":"0001650664-26-000022","document":"wk-form4_1773693348.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066426000022/wk-form4_1773693348.xml","form_type":"4"}},{"id":841090,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10100,"kind":"person","name":"Burkly Linda","position":1,"cik":"0001985604","reported_name":"Burkly Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (right to  buy)","published_at":"2026-03-16T20:34:51.000Z","date":"2026-03-12","kind":"grant","planned":true,"acquired":true,"shares":292856,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on March 12, 2026 and is scheduled to vest over four years in equal monthly installments beginning on April 12, 2026 through March 12, 2030."}],"balance_after":292856,"derivative":{"exercise_price":2.54,"expiration_date":"2036-03-11","underlying":"Common Stock","underlying_shares":292856},"source":{"system":"sec-edgar","filing":"0001650664-26-000021","document":"wk-form4_1773693286.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066426000021/wk-form4_1773693286.xml","form_type":"4"}},{"id":860636,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10088,"kind":"person","name":"O'Neill Gilmore Neil","position":1,"cik":"0001742084","reported_name":"O'Neill Gilmore Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-03-04T21:56:01.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":5394,"price":2.0197,"value":10894.2618,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 13, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 2, 2026. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $2.0050 to $2.0204 The price reported above reflects the weighted average purchase price. The Reporting Person hereby\nundertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":263693,"source":{"system":"sec-edgar","filing":"0001650664-26-000009","document":"wk-form4_1772661358.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066426000009/wk-form4_1772661358.xml","form_type":"4"}},{"id":860634,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10091,"kind":"person","name":"Parison Amy","position":1,"cik":"0002063082","reported_name":"Parison Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-04T21:49:20.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":474,"price":2.02,"value":957.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 7, 2022, and represents the sale of shares by the Issuer necessary to meet tax\nwithholding obligations as a result of vesting in restricted stock units on March 2, 2026. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $2.0050 to $2.0204. The price reported above reflects the weighted average purchase price. The Reporting Person hereby\nundertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":15434,"source":{"system":"sec-edgar","filing":"0001650664-26-000007","document":"wk-form4_1772660958.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066426000007/wk-form4_1772660958.xml","form_type":"4"}},{"id":860631,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10100,"kind":"person","name":"Burkly Linda","position":1,"cik":"0001985604","reported_name":"Burkly Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2026-03-04T21:48:40.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":749,"price":2.0196,"value":1512.6804,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax\nwithholding obligations as a result of vesting in restricted stock units on March 2, 2026. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $2.0041 to $2.0204. The price reported above reflects the weighted average purchase price. The Reporting Person hereby\nundertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected"}],"balance_after":68028,"source":{"system":"sec-edgar","filing":"0001650664-26-000006","document":"wk-form4_1772660918.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066426000006/wk-form4_1772660918.xml","form_type":"4"}},{"id":979974,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10100,"kind":"person","name":"Burkly Linda","position":1,"cik":"0001985604","reported_name":"Burkly Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2025-12-04T21:39:10.000Z","date":"2025-12-03","kind":"sale","planned":true,"acquired":false,"shares":713,"price":2.1531,"value":1535.1603,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on December 2, 2025. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":68777,"source":{"system":"sec-edgar","filing":"0001650664-25-000163","document":"wk-form4_1764884348.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000163/wk-form4_1764884348.xml","form_type":"4"}},{"id":979973,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10088,"kind":"person","name":"O'Neill Gilmore Neil","position":1,"cik":"0001742084","reported_name":"O'Neill Gilmore Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-12-04T21:38:41.000Z","date":"2025-12-03","kind":"sale","planned":true,"acquired":false,"shares":5603,"price":2.1531,"value":12063.8193,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 13, 2022, and represents the sale of shares by the Issuer necessary to meet tax\nwithholding obligations as a result of vesting in restricted stock units on December 2, 2025. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":269087,"source":{"system":"sec-edgar","filing":"0001650664-25-000162","document":"wk-form4_1764884318.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000162/wk-form4_1764884318.xml","form_type":"4"}},{"id":979969,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10091,"kind":"person","name":"Parison Amy","position":1,"cik":"0002063082","reported_name":"Parison Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-04T21:38:06.000Z","date":"2025-12-03","kind":"sale","planned":true,"acquired":false,"shares":461,"price":2.1531,"value":992.5791,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 7, 2022, and represents the sale of shares by the Issuer necessary to meet tax\nwithholding obligations as a result of vesting in restricted stock units on December 2, 2025. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":15908,"source":{"system":"sec-edgar","filing":"0001650664-25-000161","document":"wk-form4_1764884284.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000161/wk-form4_1764884284.xml","form_type":"4"}},{"id":1047518,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10100,"kind":"person","name":"Burkly Linda","position":1,"cik":"0001985604","reported_name":"Burkly Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2025-09-04T20:21:27.000Z","date":"2025-09-03","kind":"sale","planned":true,"acquired":false,"shares":710,"price":2.5961,"value":1843.231,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax\nwithholding obligations as a result of vesting in restricted stock units on September 2, 2025. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount of securities beneficially owned following the reported transaction includes 5,802 shares acquired under the Issuer's Employee Stock Purchase Plan."}],"balance_after":69490,"source":{"system":"sec-edgar","filing":"0001650664-25-000143","document":"wk-form4_1757017284.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000143/wk-form4_1757017284.xml","form_type":"4"}},{"id":1047525,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10091,"kind":"person","name":"Parison Amy","position":1,"cik":"0002063082","reported_name":"Parison Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-04T20:20:48.000Z","date":"2025-09-03","kind":"sale","planned":true,"acquired":false,"shares":458,"price":2.5961,"value":1189.0138,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 7, 2022, and represents the sale of shares by the Issuer necessary to meet tax\nwithholding obligations as a result of vesting in restricted stock units on September 2, 2025. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":16369,"source":{"system":"sec-edgar","filing":"0001650664-25-000142","document":"wk-form4_1757017244.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000142/wk-form4_1757017244.xml","form_type":"4"}},{"id":1047511,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10088,"kind":"person","name":"O'Neill Gilmore Neil","position":1,"cik":"0001742084","reported_name":"O'Neill Gilmore Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-09-04T20:20:00.000Z","date":"2025-09-03","kind":"sale","planned":true,"acquired":false,"shares":5592,"price":2.5961,"value":14517.3912,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 13, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 2, 2025. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":274690,"source":{"system":"sec-edgar","filing":"0001650664-25-000141","document":"wk-form4_1757017197.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000141/wk-form4_1757017197.xml","form_type":"4"}},{"id":1071068,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10091,"kind":"person","name":"Parison Amy","position":1,"cik":"0002063082","reported_name":"Parison Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-08T20:28:02.000Z","date":"2025-08-07","kind":"sale","planned":true,"acquired":false,"shares":679,"price":2.58,"value":1751.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 7, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on June 6, 2025. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":16827,"source":{"system":"sec-edgar","filing":"0001650664-25-000118","document":"wk-form4_1754684878.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000118/wk-form4_1754684878.xml","form_type":"4"}},{"id":1075981,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10100,"kind":"person","name":"Burkly Linda","position":1,"cik":"0001985604","reported_name":"Burkly Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2025-08-04T20:49:50.000Z","date":"2025-07-31","kind":"sale","planned":true,"acquired":false,"shares":5121,"price":2.4911,"value":12756.9231,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on July 24, 2025. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":64398,"source":{"system":"sec-edgar","filing":"0001650664-25-000113","document":"wk-form4_1754340586.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000113/wk-form4_1754340586.xml","form_type":"4"}},{"id":1115977,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to  buy)","published_at":"2025-06-10T20:19:40.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 6, 2025 and is scheduled to vest in full on June 6, 2026."}],"balance_after":37500,"derivative":{"exercise_price":1.91,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001650664-25-000103","document":"wk-form4_1749586773.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1648715/000165066425000103/wk-form4_1749586773.xml","form_type":"4"}},{"id":1115974,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":35959,"kind":"person","name":"Scadden David","position":1,"cik":"0001707715","reported_name":"Scadden David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to  buy)","published_at":"2025-06-10T20:19:16.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 6, 2025 and is scheduled to vest in full on June 6, 2026."}],"balance_after":37500,"derivative":{"exercise_price":1.91,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001650664-25-000102","document":"wk-form4_1749586749.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000102/wk-form4_1749586749.xml","form_type":"4"}},{"id":1116468,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":35687,"kind":"person","name":"Levy Elliott M.","position":1,"cik":"0001858745","reported_name":"Levy Elliott M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to  buy)","published_at":"2025-06-10T20:18:49.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 6, 2025 and is scheduled to vest in full on June 6, 2026."}],"balance_after":37500,"derivative":{"exercise_price":1.91,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001650664-25-000101","document":"wk-form4_1749586723.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858745/000165066425000101/wk-form4_1749586723.xml","form_type":"4"}},{"id":1115973,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":24717,"kind":"person","name":"Connaughton Bernadette","position":1,"cik":"0001662521","reported_name":"Connaughton Bernadette","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to  buy)","published_at":"2025-06-10T20:18:24.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 6, 2025 and is scheduled to vest in full on June 6, 2026."}],"balance_after":37500,"derivative":{"exercise_price":1.91,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001650664-25-000100","document":"wk-form4_1749586697.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000100/wk-form4_1749586697.xml","form_type":"4"}},{"id":1115989,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":36225,"kind":"person","name":"Hirsch Andrew","position":1,"cik":"0001586707","reported_name":"Hirsch Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to  buy)","published_at":"2025-06-10T20:18:00.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 6, 2025 and is scheduled to vest in full on June 6, 2026."}],"balance_after":37500,"derivative":{"exercise_price":1.91,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001650664-25-000099","document":"wk-form4_1749586673.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586707/000165066425000099/wk-form4_1749586673.xml","form_type":"4"}},{"id":1122362,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10091,"kind":"person","name":"Parison Amy","position":1,"cik":"0002063082","reported_name":"Parison Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-04T22:39:21.000Z","date":"2025-06-03","kind":"sale","planned":true,"acquired":false,"shares":446,"price":1.724,"value":768.904,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 7, 2022, and represents the sale of shares by the Issuer necessary to meet tax\nwithholding obligations as a result of vesting in restricted stock units on June 2, 2025. The sale does not represent a discretionary trade by the Reporting Person"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $1.7239 to $1.7522. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":17506,"source":{"system":"sec-edgar","filing":"0001650664-25-000093","document":"wk-form4_1749076755.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000093/wk-form4_1749076755.xml","form_type":"4"}},{"id":1122361,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10100,"kind":"person","name":"Burkly Linda","position":1,"cik":"0001985604","reported_name":"Burkly Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2025-06-04T22:37:51.000Z","date":"2025-06-03","kind":"sale","planned":true,"acquired":false,"shares":726,"price":1.7243,"value":1251.8418,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on June 2, 2025. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $1.7239 to $1.7522. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":69519,"source":{"system":"sec-edgar","filing":"0001650664-25-000091","document":"wk-form4_1749076666.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000091/wk-form4_1749076666.xml","form_type":"4"}},{"id":1122360,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10088,"kind":"person","name":"O'Neill Gilmore Neil","position":1,"cik":"0001742084","reported_name":"O'Neill Gilmore Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-06-04T22:36:39.000Z","date":"2025-06-03","kind":"sale","planned":true,"acquired":false,"shares":15192,"price":1.7243,"value":26195.5656,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 13, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on June 2, 2025. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $1.7239 to $1.7566 . The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":280282,"source":{"system":"sec-edgar","filing":"0001650664-25-000089","document":"wk-form4_1749076593.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000089/wk-form4_1749076593.xml","form_type":"4"}},{"id":1175176,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10091,"kind":"person","name":"Parison Amy","position":1,"cik":"0002063082","reported_name":"Parison Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Stock Option (right to  buy)","published_at":"2025-04-08T20:29:42.000Z","date":"2025-04-08","kind":"grant","planned":false,"acquired":true,"shares":34672,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on April 8, 2025 and is scheduled to vest over four years, with 25% of the shares to vest on April 8, 2026 and the remaining 75% of the shares scheduled to vest in equal monthly  monthly installments thereafter through April 8, 2029."}],"balance_after":34672,"derivative":{"exercise_price":0.98,"expiration_date":"2035-04-07","underlying":"Common Stock","underlying_shares":34672},"source":{"system":"sec-edgar","filing":"0001650664-25-000052","document":"wk-form4_1744144175.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000052/wk-form4_1744144175.xml","form_type":"4"}},{"id":1189489,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to  buy)","published_at":"2025-03-27T20:41:59.000Z","date":"2025-03-08","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on March 8, 2025 and is scheduled to vest in full on September 8, 2026."}],"balance_after":70000,"derivative":{"exercise_price":1.72,"expiration_date":"2035-03-07","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001650664-25-000040","document":"wk-form4_1743108110.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000040/wk-form4_1743108110.xml","form_type":"4"}},{"id":1189488,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to  buy)","published_at":"2025-03-27T20:41:59.000Z","date":"2025-03-08","kind":"grant","planned":false,"acquired":true,"shares":275100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on March 8, 2025 and is scheduled to vest over four years in equal monthly installments beginning on April 8, 2025 through March 8, 2029."}],"balance_after":275100,"derivative":{"exercise_price":1.72,"expiration_date":"2035-03-07","underlying":"Common Stock","underlying_shares":275100},"source":{"system":"sec-edgar","filing":"0001650664-25-000040","document":"wk-form4_1743108110.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000040/wk-form4_1743108110.xml","form_type":"4"}},{"id":1189487,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10088,"kind":"person","name":"O'Neill Gilmore Neil","position":1,"cik":"0001742084","reported_name":"O'Neill Gilmore Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (right to  buy)","published_at":"2025-03-27T20:37:39.000Z","date":"2025-03-08","kind":"grant","planned":false,"acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on March 8, 2025 and is scheduled to vest in full on September 8, 2026."}],"balance_after":175000,"derivative":{"exercise_price":1.72,"expiration_date":"2035-03-07","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001650664-25-000037","document":"wk-form4_1743107853.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000037/wk-form4_1743107853.xml","form_type":"4"}},{"id":1189486,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10088,"kind":"person","name":"O'Neill Gilmore Neil","position":1,"cik":"0001742084","reported_name":"O'Neill Gilmore Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (right to  buy)","published_at":"2025-03-27T20:37:39.000Z","date":"2025-03-08","kind":"grant","planned":false,"acquired":true,"shares":828000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on March 8, 2025 and is scheduled to vest over four years in equal monthly installments beginning on April 8, 2025 through March 8, 2029."}],"balance_after":828000,"derivative":{"exercise_price":1.72,"expiration_date":"2035-03-07","underlying":"Common Stock","underlying_shares":828000},"source":{"system":"sec-edgar","filing":"0001650664-25-000037","document":"wk-form4_1743107853.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000037/wk-form4_1743107853.xml","form_type":"4"}},{"id":1189485,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10100,"kind":"person","name":"Burkly Linda","position":1,"cik":"0001985604","reported_name":"Burkly Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (right to  buy)","published_at":"2025-03-27T20:33:48.000Z","date":"2025-03-08","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on March 8, 2025 and is scheduled to vest in full on September 8, 2026."}],"balance_after":70000,"derivative":{"exercise_price":1.72,"expiration_date":"2035-03-07","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001650664-25-000034","document":"wk-form4_1743107610.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000034/wk-form4_1743107610.xml","form_type":"4"}},{"id":1189484,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10100,"kind":"person","name":"Burkly Linda","position":1,"cik":"0001985604","reported_name":"Burkly Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (right to  buy)","published_at":"2025-03-27T20:33:48.000Z","date":"2025-03-08","kind":"grant","planned":false,"acquired":true,"shares":275100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on March 8, 2025 and is scheduled to vest over four years in equal monthly installments beginning on April 8, 2025 through March 8, 2029."}],"balance_after":275100,"derivative":{"exercise_price":1.72,"expiration_date":"2035-03-07","underlying":"Common Stock","underlying_shares":275100},"source":{"system":"sec-edgar","filing":"0001650664-25-000034","document":"wk-form4_1743107610.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000034/wk-form4_1743107610.xml","form_type":"4"}},{"id":1221567,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-03-05T21:44:08.000Z","date":"2025-03-04","kind":"sale","planned":true,"acquired":false,"shares":4109,"price":1.7108,"value":7029.6772,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on May 12, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 3, 2025. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $1.7107 to $1.7150 . The price reported above reflects the weighted average purchase price. The Reporting Person hereby\nundertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":112720,"source":{"system":"sec-edgar","filing":"0001650664-25-000027","document":"wk-form4_1741211041.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000027/wk-form4_1741211041.xml","form_type":"4"}},{"id":1221566,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10088,"kind":"person","name":"O'Neill Gilmore Neil","position":1,"cik":"0001742084","reported_name":"O'Neill Gilmore Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-03-05T21:43:12.000Z","date":"2025-03-04","kind":"sale","planned":true,"acquired":false,"shares":16632,"price":1.7107,"value":28452.3624,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 13, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 3, 2025. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $1.7107 to $1.7125 . The price reported above reflects the weighted average purchase price. The Reporting Person hereby\nundertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":295474,"source":{"system":"sec-edgar","filing":"0001650664-25-000026","document":"wk-form4_1741210979.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000026/wk-form4_1741210979.xml","form_type":"4"}},{"id":1221565,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10100,"kind":"person","name":"Burkly Linda","position":1,"cik":"0001985604","reported_name":"Burkly Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2025-03-05T21:41:55.000Z","date":"2025-03-04","kind":"sale","planned":true,"acquired":false,"shares":2891,"price":1.7107,"value":4945.6337,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 2, 2025. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":70245,"source":{"system":"sec-edgar","filing":"0001650664-25-000025","document":"wk-form4_1741210903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000025/wk-form4_1741210903.xml","form_type":"4"}},{"id":1341293,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10088,"kind":"person","name":"O'Neill Gilmore Neil","position":1,"cik":"0001742084","reported_name":"O'Neill Gilmore Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-12-05T21:40:31.000Z","date":"2024-12-03","kind":"sale","planned":true,"acquired":false,"shares":1618,"price":2.0774,"value":3361.2332,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 13, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on December  2, 2024. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $2.0550 to $2.0783. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":312106,"source":{"system":"sec-edgar","filing":"0001650664-24-000126","document":"wk-form4_1733434825.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000126/wk-form4_1733434825.xml","form_type":"4"}},{"id":1341292,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":85396,"kind":"person","name":"Mei Baisong","position":1,"cik":"0001938499","reported_name":"Mei Baisong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-12-05T21:37:25.000Z","date":"2024-12-03","kind":"sale","planned":true,"acquired":false,"shares":541,"price":2.0772,"value":1123.7652,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 14, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on December 2, 2024. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $2.0507  to $2.0783. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":133354,"source":{"system":"sec-edgar","filing":"0001650664-24-000124","document":"wk-form4_1733434638.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000124/wk-form4_1733434638.xml","form_type":"4"}},{"id":1412509,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":85396,"kind":"person","name":"Mei Baisong","position":1,"cik":"0001938499","reported_name":"Mei Baisong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-09-06T20:20:37.000Z","date":"2024-09-04","kind":"sale","planned":true,"acquired":false,"shares":518,"price":3.4247,"value":1773.9946,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 14, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 2, 2024. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $3.4246 to $3.4501. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":133895,"source":{"system":"sec-edgar","filing":"0001650664-24-000105","document":"wk-form4_1725654028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000105/wk-form4_1725654028.xml","form_type":"4"}},{"id":1412508,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10088,"kind":"person","name":"O'Neill Gilmore Neil","position":1,"cik":"0001742084","reported_name":"O'Neill Gilmore Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-09-06T20:18:20.000Z","date":"2024-09-04","kind":"sale","planned":true,"acquired":false,"shares":1555,"price":3.4247,"value":5325.4085,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 13, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 2, 2024. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $3.4246 to $3.4503. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":313724,"source":{"system":"sec-edgar","filing":"0001650664-24-000103","document":"wk-form4_1725653893.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000103/wk-form4_1725653893.xml","form_type":"4"}},{"id":1447893,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10100,"kind":"person","name":"Burkly Linda","position":1,"cik":"0001985604","reported_name":"Burkly Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2024-07-26T21:02:15.000Z","date":"2024-07-25","kind":"sale","planned":true,"acquired":false,"shares":11886,"price":5.4156,"value":64369.8216,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on July 24, 2024. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":73136,"source":{"system":"sec-edgar","filing":"0001650664-24-000090","document":"wk-form4_1722027729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000090/wk-form4_1722027729.xml","form_type":"4"}},{"id":1450308,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":85396,"kind":"person","name":"Mei Baisong","position":1,"cik":"0001938499","reported_name":"Mei Baisong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-07-22T21:01:17.000Z","date":"2024-07-19","kind":"sale","planned":true,"acquired":false,"shares":6619,"price":5.2056,"value":34455.8664,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 14, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on July 18, 2024. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $5.1650 to $5.2058. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":134413,"source":{"system":"sec-edgar","filing":"0001650664-24-000087","document":"wk-form4_1721682068.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000087/wk-form4_1721682068.xml","form_type":"4"}},{"id":1488032,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10088,"kind":"person","name":"O'Neill Gilmore Neil","position":1,"cik":"0001742084","reported_name":"O'Neill Gilmore Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-06-06T20:17:11.000Z","date":"2024-06-04","kind":"sale","planned":true,"acquired":false,"shares":12191,"price":5.4956,"value":66996.8596,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 13, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on June 2, 2024. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":315279,"source":{"system":"sec-edgar","filing":"0001650664-24-000076","document":"wk-form4_1717705020.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000076/wk-form4_1717705020.xml","form_type":"4"}},{"id":1488031,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":85396,"kind":"person","name":"Mei Baisong","position":1,"cik":"0001938499","reported_name":"Mei Baisong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-06-06T20:16:13.000Z","date":"2024-06-04","kind":"sale","planned":true,"acquired":false,"shares":511,"price":5.4956,"value":2808.2516,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on  June 14, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on June 2, 2024. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":141032,"source":{"system":"sec-edgar","filing":"0001650664-24-000075","document":"wk-form4_1717704962.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000075/wk-form4_1717704962.xml","form_type":"4"}},{"id":1494755,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":35959,"kind":"person","name":"Scadden David","position":1,"cik":"0001707715","reported_name":"Scadden David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to  buy)","published_at":"2024-06-03T21:15:27.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 30, 2024 and is scheduled to vest in full on May 30, 2025"}],"balance_after":25000,"derivative":{"exercise_price":5.17,"expiration_date":"2034-05-29","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001650664-24-000072","document":"wk-form4_1717449318.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000072/wk-form4_1717449318.xml","form_type":"4"}},{"id":1494756,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to  buy)","published_at":"2024-06-03T21:14:39.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 30, 2024  and is scheduled to vest in full on May 30, 2025."}],"balance_after":25000,"derivative":{"exercise_price":5.17,"expiration_date":"2034-05-29","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001650664-24-000071","document":"wk-form4_1717449268.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1648715/000165066424000071/wk-form4_1717449268.xml","form_type":"4"}},{"id":1494754,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":78493,"kind":"person","name":"Chatterjee Meeta","position":1,"cik":"0001835388","reported_name":"Chatterjee Meeta","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to  buy)","published_at":"2024-06-03T21:13:53.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 30, 2024 and is scheduled to vest in full on May 30, 2025."}],"balance_after":25000,"derivative":{"exercise_price":5.17,"expiration_date":"2034-05-29","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001650664-24-000070","document":"wk-form4_1717449223.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000070/wk-form4_1717449223.xml","form_type":"4"}},{"id":1494805,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":36225,"kind":"person","name":"Hirsch Andrew","position":1,"cik":"0001586707","reported_name":"Hirsch Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to  buy)","published_at":"2024-06-03T21:11:14.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 30, 2024 and is scheduled to vest in full on May 30, 2025."}],"balance_after":25000,"derivative":{"exercise_price":5.17,"expiration_date":"2034-05-29","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001650664-24-000068","document":"wk-form4_1717449062.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586707/000165066424000068/wk-form4_1717449062.xml","form_type":"4"}},{"id":1494753,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":38135,"kind":"person","name":"Reeve Emma","position":1,"cik":"0001680329","reported_name":"Reeve Emma","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to  buy)","published_at":"2024-06-03T20:30:27.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 30, 2024 and is scheduled to vest in full on  May 30, 2025"}],"balance_after":25000,"derivative":{"exercise_price":5.17,"expiration_date":"2034-05-29","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001650664-24-000060","document":"wk-form4_1717446617.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000060/wk-form4_1717446617.xml","form_type":"4"}},{"id":1495318,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":35687,"kind":"person","name":"Levy Elliott M.","position":1,"cik":"0001858745","reported_name":"Levy Elliott M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to  buy)","published_at":"2024-06-03T20:27:28.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 30, 2024  and is scheduled to vest in full on May 30, 2025."}],"balance_after":25000,"derivative":{"exercise_price":5.17,"expiration_date":"2034-05-29","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001650664-24-000058","document":"wk-form4_1717446440.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858745/000165066424000058/wk-form4_1717446440.xml","form_type":"4"}},{"id":1494752,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":24717,"kind":"person","name":"Connaughton Bernadette","position":1,"cik":"0001662521","reported_name":"Connaughton Bernadette","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to  buy)","published_at":"2024-06-03T20:25:34.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 30, 2024 and is scheduled to vest in full on May 30, 2025."}],"balance_after":25000,"derivative":{"exercise_price":5.17,"expiration_date":"2034-05-29","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001650664-24-000056","document":"wk-form4_1717446325.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000056/wk-form4_1717446325.xml","form_type":"4"}},{"id":1495026,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":50572,"kind":"person","name":"Vaishnaw Akshay","position":1,"cik":"0001458494","reported_name":"Vaishnaw Akshay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to  buy)","published_at":"2024-06-03T20:22:55.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 30, 2024 and is scheduled to vest in full on May 30, 2025."}],"balance_after":25000,"derivative":{"exercise_price":5.17,"expiration_date":"2034-05-29","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001650664-24-000054","document":"wk-form4_1717446166.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458494/000165066424000054/wk-form4_1717446166.xml","form_type":"4"}},{"id":1505050,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-05-22T20:30:13.000Z","date":"2024-05-20","kind":"sale","planned":true,"acquired":false,"shares":22337,"price":5.6142,"value":125404.3854,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on May 12, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on May 17, 2024. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":116829,"source":{"system":"sec-edgar","filing":"0001650664-24-000044","document":"wk-form4_1716409797.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000044/wk-form4_1716409797.xml","form_type":"4"}},{"id":1516960,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-14T20:17:23.000Z","date":"2024-05-13","kind":"purchase","planned":false,"acquired":true,"shares":45000,"price":5.6415,"value":253867.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $5.43 to $5.83. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":67700,"source":{"system":"sec-edgar","filing":"0001650664-24-000039","document":"wk-form4_1715717825.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1648715/000165066424000039/wk-form4_1715717825.xml","form_type":"4"}},{"id":1593960,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to  buy)","published_at":"2024-03-06T01:06:54.000Z","date":"2024-03-02","kind":"grant","planned":false,"acquired":true,"shares":106000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on March 2, 2024 and is scheduled to vest over four years in equal monthly installments beginning on  April 2, 2024 through March 2, 2028."}],"balance_after":106000,"derivative":{"exercise_price":10.53,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":106000},"source":{"system":"sec-edgar","filing":"0001650664-24-000019","document":"wk-form4_1709687193.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000019/wk-form4_1709687193.xml","form_type":"4"}},{"id":1593959,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-06T01:06:54.000Z","date":"2024-03-02","kind":"grant","planned":false,"acquired":true,"shares":25966,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects the acquisition, upon the achievement of a specified business development milestone, of a portion of a performance-based restricted stock unit award originally granted on May 17, 2023. The shares subject to the restricted stock unit award remain subject to time-based vesting conditions and will vest on  May 17, 2024, subject to continued service."}],"balance_after":139166,"source":{"system":"sec-edgar","filing":"0001650664-24-000019","document":"wk-form4_1709687193.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000019/wk-form4_1709687193.xml","form_type":"4"}},{"id":1593958,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-06T01:06:54.000Z","date":"2024-03-02","kind":"grant","planned":false,"acquired":true,"shares":35300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years with 25% of the units vesting on March 2, 2025 and the remaining 75% of the units scheduled to vest in equal quarterly installments thereafter through March 2, 2028."}],"balance_after":113200,"source":{"system":"sec-edgar","filing":"0001650664-24-000019","document":"wk-form4_1709687193.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000019/wk-form4_1709687193.xml","form_type":"4"}},{"id":1593957,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10100,"kind":"person","name":"Burkly Linda","position":1,"cik":"0001985604","reported_name":"Burkly Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (right to  buy)","published_at":"2024-03-06T01:03:36.000Z","date":"2024-03-02","kind":"grant","planned":false,"acquired":true,"shares":74400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on March 2, 2024 and is scheduled to vest over four years in equal monthly installments beginning on  April 2, 2024 through March 2, 2028."}],"balance_after":74400,"derivative":{"exercise_price":10.53,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":74400},"source":{"system":"sec-edgar","filing":"0001650664-24-000017","document":"wk-form4_1709686999.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000017/wk-form4_1709686999.xml","form_type":"4"}},{"id":1593956,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10100,"kind":"person","name":"Burkly Linda","position":1,"cik":"0001985604","reported_name":"Burkly Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2024-03-06T01:03:36.000Z","date":"2024-03-02","kind":"grant","planned":false,"acquired":true,"shares":15055,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects the acquisition, upon the achievement of a specified business development milestone, of a portion of a performance-based restricted stock unit award originally granted on July 24, 2023. The shares subject to the restricted stock unit award remain subject to time-based vesting conditions and will vest on July 24, 2024, subject to continued service."}],"balance_after":85022,"source":{"system":"sec-edgar","filing":"0001650664-24-000017","document":"wk-form4_1709686999.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000017/wk-form4_1709686999.xml","form_type":"4"}},{"id":1593955,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10100,"kind":"person","name":"Burkly Linda","position":1,"cik":"0001985604","reported_name":"Burkly Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2024-03-06T01:03:36.000Z","date":"2024-03-02","kind":"grant","planned":false,"acquired":true,"shares":24800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years with 25% of the units vesting on March 2, 2025 and the remaining 75% of the units scheduled to vest in equal quarterly installments thereafter through March 2, 2028."}],"balance_after":69967,"source":{"system":"sec-edgar","filing":"0001650664-24-000017","document":"wk-form4_1709686999.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000017/wk-form4_1709686999.xml","form_type":"4"}},{"id":1593954,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10088,"kind":"person","name":"O'Neill Gilmore Neil","position":1,"cik":"0001742084","reported_name":"O'Neill Gilmore Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (right to  buy)","published_at":"2024-03-06T01:00:16.000Z","date":"2024-03-02","kind":"grant","planned":true,"acquired":true,"shares":392100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was granted on March 2, 2024 and is scheduled to vest over four years in equal monthly installments beginning on  April 2, 2024 through March 2, 2028."}],"balance_after":392100,"derivative":{"exercise_price":10.53,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":392100},"source":{"system":"sec-edgar","filing":"0001650664-24-000015","document":"wk-form4_1709686792.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000015/wk-form4_1709686792.xml","form_type":"4"}},{"id":1593953,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10088,"kind":"person","name":"O'Neill Gilmore Neil","position":1,"cik":"0001742084","reported_name":"O'Neill Gilmore Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-03-06T01:00:16.000Z","date":"2024-03-05","kind":"sale","planned":true,"acquired":false,"shares":77824,"price":9.4172,"value":732884.1728,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 13, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 2, 2024. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $9.1036 to $9.4298. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":327470,"source":{"system":"sec-edgar","filing":"0001650664-24-000015","document":"wk-form4_1709686792.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000015/wk-form4_1709686792.xml","form_type":"4"}},{"id":1593952,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10088,"kind":"person","name":"O'Neill Gilmore Neil","position":1,"cik":"0001742084","reported_name":"O'Neill Gilmore Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-03-06T01:00:16.000Z","date":"2024-03-02","kind":"grant","planned":true,"acquired":true,"shares":72212,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Reflects the vesting, upon the achievement of a business development milestone, of a portion of a performance-based restricted stock unit award originally granted on June 2, 2022."}],"balance_after":405294,"source":{"system":"sec-edgar","filing":"0001650664-24-000015","document":"wk-form4_1709686792.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000015/wk-form4_1709686792.xml","form_type":"4"}},{"id":1593951,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10088,"kind":"person","name":"O'Neill Gilmore Neil","position":1,"cik":"0001742084","reported_name":"O'Neill Gilmore Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-03-06T01:00:16.000Z","date":"2024-03-02","kind":"grant","planned":true,"acquired":true,"shares":72213,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects the vesting, upon the achievement of a specified research and development milestone, of a portion of a performance-based restricted stock unit award originally granted on June 2, 2022."}],"balance_after":333082,"source":{"system":"sec-edgar","filing":"0001650664-24-000015","document":"wk-form4_1709686792.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000015/wk-form4_1709686792.xml","form_type":"4"}},{"id":1593950,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10088,"kind":"person","name":"O'Neill Gilmore Neil","position":1,"cik":"0001742084","reported_name":"O'Neill Gilmore Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-03-06T01:00:16.000Z","date":"2024-03-02","kind":"grant","planned":true,"acquired":true,"shares":130700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years with 25% of the units vesting on March 2, 2025 and the remaining 75% of the units scheduled to vest in equal quarterly installments thereafter through March 2, 2028."}],"balance_after":260869,"source":{"system":"sec-edgar","filing":"0001650664-24-000015","document":"wk-form4_1709686792.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000015/wk-form4_1709686792.xml","form_type":"4"}},{"id":1593949,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":85396,"kind":"person","name":"Mei Baisong","position":1,"cik":"0001938499","reported_name":"Mei Baisong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (right to  buy)","published_at":"2024-03-06T00:54:42.000Z","date":"2024-03-02","kind":"grant","planned":true,"acquired":true,"shares":152800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was granted on March 2, 2024 and is scheduled to vest over four years in equal monthly installments beginning on  April  2, 2024 through March 2, 2028."}],"balance_after":152800,"derivative":{"exercise_price":10.53,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":152800},"source":{"system":"sec-edgar","filing":"0001650664-24-000013","document":"wk-form4_1709686469.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000013/wk-form4_1709686469.xml","form_type":"4"}},{"id":1593948,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":85396,"kind":"person","name":"Mei Baisong","position":1,"cik":"0001938499","reported_name":"Mei Baisong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-06T00:54:42.000Z","date":"2024-03-04","kind":"sale","planned":true,"acquired":false,"shares":20327,"price":9.4173,"value":191425.4571,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 14, 2022 and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 2, 2024. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $9.1036 to $9.4298. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":141543,"source":{"system":"sec-edgar","filing":"0001650664-24-000013","document":"wk-form4_1709686469.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000013/wk-form4_1709686469.xml","form_type":"4"}},{"id":1593947,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":85396,"kind":"person","name":"Mei Baisong","position":1,"cik":"0001938499","reported_name":"Mei Baisong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-06T00:54:42.000Z","date":"2024-03-02","kind":"grant","planned":true,"acquired":true,"shares":19457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Reflects the vesting, upon the achievement of a business development milestone, of a portion of a performance-based  restricted stock unit award  originally granted on July 18, 2022."}],"balance_after":161870,"source":{"system":"sec-edgar","filing":"0001650664-24-000013","document":"wk-form4_1709686469.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000013/wk-form4_1709686469.xml","form_type":"4"}},{"id":1593946,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":85396,"kind":"person","name":"Mei Baisong","position":1,"cik":"0001938499","reported_name":"Mei Baisong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-06T00:54:42.000Z","date":"2024-03-02","kind":"grant","planned":true,"acquired":true,"shares":19458,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects the vesting, upon the achievement of a specified research and development milestone, of a portion of a performance-based restricted stock unit award originally granted on July 18, 2022."}],"balance_after":142413,"source":{"system":"sec-edgar","filing":"0001650664-24-000013","document":"wk-form4_1709686469.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000013/wk-form4_1709686469.xml","form_type":"4"}},{"id":1593945,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":85396,"kind":"person","name":"Mei Baisong","position":1,"cik":"0001938499","reported_name":"Mei Baisong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-06T00:54:42.000Z","date":"2024-03-02","kind":"grant","planned":true,"acquired":true,"shares":50900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years with 25% of the units vesting on March 2, 2025 and the remaining 75% of the units scheduled to vest in equal quarterly installments thereafter through March 2, 2028."}],"balance_after":122955,"source":{"system":"sec-edgar","filing":"0001650664-24-000013","document":"wk-form4_1709686469.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000013/wk-form4_1709686469.xml","form_type":"4"}},{"id":1719190,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":107692,"kind":"person","name":"Eaton Bruce","position":1,"cik":"0001874831","reported_name":"Eaton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO AND CTO"}}],"security":"Common Stock","published_at":"2023-12-07T16:30:36.000Z","date":"2023-12-05","kind":"sale","planned":true,"acquired":false,"shares":103,"price":10.8972,"value":1122.4116,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on December 2, 2023. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $10.6149 to $10.9000. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":74791,"source":{"system":"sec-edgar","filing":"0001650664-23-000029","document":"wk-form4_1701984627.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874831/000165066423000029/wk-form4_1701984627.xml","form_type":"4"}},{"id":1739332,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":107692,"kind":"person","name":"Eaton Bruce","position":1,"cik":"0001874831","reported_name":"Eaton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO AND CTO"}}],"security":"Common Stock","published_at":"2023-11-16T16:30:49.000Z","date":"2023-11-14","kind":"sale","planned":true,"acquired":false,"shares":695,"price":8.2096,"value":5705.672,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on November 10, 2023. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":74894,"source":{"system":"sec-edgar","filing":"0001650664-23-000022","document":"wk-form4_1700170220.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874831/000165066423000022/wk-form4_1700170220.xml","form_type":"4"}},{"id":1745874,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":107692,"kind":"person","name":"Eaton Bruce","position":1,"cik":"0001874831","reported_name":"Eaton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO AND CTO"}}],"security":"Common Stock","published_at":"2023-11-09T16:31:26.000Z","date":"2023-11-07","kind":"sale","planned":true,"acquired":false,"shares":139,"price":8.4,"value":1167.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on November 6, 2023. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":75589,"source":{"system":"sec-edgar","filing":"0001650664-23-000019","document":"wk-form4_1699565469.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874831/000165066423000019/wk-form4_1699565469.xml","form_type":"4"}},{"id":1786047,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":107692,"kind":"person","name":"Eaton Bruce","position":1,"cik":"0001874831","reported_name":"Eaton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO AND CTO"}}],"security":"Common Stock","published_at":"2023-09-07T16:59:37.000Z","date":"2023-09-06","kind":"sale","planned":true,"acquired":false,"shares":103,"price":8.82,"value":908.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 2, 2023. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":75728,"source":{"system":"sec-edgar","filing":"0001650664-23-000002","document":"wk-form4_1694120355.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874831/000165066423000002/wk-form4_1694120355.xml","form_type":"4"}},{"id":1807486,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":107692,"kind":"person","name":"Eaton Bruce","position":1,"cik":"0001874831","reported_name":"Eaton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO AND CTO"}}],"security":"Common Stock","published_at":"2023-08-15T16:30:14.000Z","date":"2023-08-11","kind":"sale","planned":true,"acquired":false,"shares":702,"price":8.5935,"value":6032.637,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on August 10, 2023. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":75831,"source":{"system":"sec-edgar","filing":"0001415889-23-012264","document":"form4-08152023_040803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874831/000141588923012264/form4-08152023_040803.xml","form_type":"4"}},{"id":1811029,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":107692,"kind":"person","name":"Eaton Bruce","position":1,"cik":"0001874831","reported_name":"Eaton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO AND CTO"}}],"security":"Common Stock","published_at":"2023-08-10T16:30:59.000Z","date":"2023-08-08","kind":"sale","planned":true,"acquired":false,"shares":141,"price":8.39,"value":1182.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on August 6, 2023. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":76533,"source":{"system":"sec-edgar","filing":"0001415889-23-012049","document":"form4-08102023_040848.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874831/000141588923012049/form4-08102023_040848.xml","form_type":"4"}},{"id":1823384,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10100,"kind":"person","name":"Burkly Linda","position":1,"cik":"0001985604","reported_name":"Burkly Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (right to  buy)","published_at":"2023-07-25T20:45:05.000Z","date":"2023-07-24","kind":"grant","planned":false,"acquired":true,"shares":135500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on July 24, 2023 and is scheduled to vest over four years, with 25% of the shares to vest on July 24, 2024 and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through July 24, 2027."}],"balance_after":135500,"derivative":{"exercise_price":8.66,"expiration_date":"2033-07-23","underlying":"Common Stock","underlying_shares":135500},"source":{"system":"sec-edgar","filing":"0001415889-23-011455","document":"form4-07252023_040701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000141588923011455/form4-07252023_040701.xml","form_type":"4"}},{"id":1823383,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10100,"kind":"person","name":"Burkly Linda","position":1,"cik":"0001985604","reported_name":"Burkly Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2023-07-25T20:45:05.000Z","date":"2023-07-24","kind":"grant","planned":false,"acquired":true,"shares":45167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years in equal yearly installments of one-fourth of the shares, with the first such installment to vest on July 24, 2024 continuing through July 24, 2027."}],"balance_after":45167,"source":{"system":"sec-edgar","filing":"0001415889-23-011455","document":"form4-07252023_040701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000141588923011455/form4-07252023_040701.xml","form_type":"4"}},{"id":1824653,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":85396,"kind":"person","name":"Mei Baisong","position":1,"cik":"0001938499","reported_name":"Mei Baisong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2023-07-21T20:30:09.000Z","date":"2023-07-19","kind":"sale","planned":true,"acquired":false,"shares":4317,"price":8.8,"value":37989.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 14, 2022 and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on July 18, 2023. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":72055,"source":{"system":"sec-edgar","filing":"0001415889-23-011382","document":"form4-07212023_040701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000141588923011382/form4-07212023_040701.xml","form_type":"4"}},{"id":1863458,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10088,"kind":"person","name":"O'Neill Gilmore Neil","position":1,"cik":"0001742084","reported_name":"O'Neill Gilmore Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-06-07T20:30:21.000Z","date":"2023-06-05","kind":"sale","planned":true,"acquired":false,"shares":6486,"price":9.5032,"value":61637.7552,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 13, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on June 2, 2023. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $9.4600 to $9.5034. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":130169,"source":{"system":"sec-edgar","filing":"0001415889-23-009369","document":"form4-06072023_040605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000141588923009369/form4-06072023_040605.xml","form_type":"4"}},{"id":1864151,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":107692,"kind":"person","name":"Eaton Bruce","position":1,"cik":"0001874831","reported_name":"Eaton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO AND CTO"}}],"security":"Common Stock","published_at":"2023-06-07T16:30:07.000Z","date":"2023-06-05","kind":"sale","planned":true,"acquired":false,"shares":105,"price":9.503,"value":997.815,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on June 2, 2023. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $9.4618 to $9.5034. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":76674,"source":{"system":"sec-edgar","filing":"0001415889-23-009368","document":"form4-06072023_040602.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874831/000141588923009368/form4-06072023_040602.xml","form_type":"4"}},{"id":1866071,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-05T20:30:47.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 1, 2023 and will vest in full on June 1, 2024."}],"balance_after":25000,"derivative":{"exercise_price":9.55,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-23-009232","document":"form4-06052023_040609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1648715/000141588923009232/form4-06052023_040609.xml","form_type":"4"}},{"id":1866070,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":24717,"kind":"person","name":"Connaughton Bernadette","position":1,"cik":"0001662521","reported_name":"Connaughton Bernadette","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-05T20:30:44.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 1, 2023 and is scheduled to vest in full on June 1, 2024."}],"balance_after":25000,"derivative":{"exercise_price":9.55,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-23-009236","document":"form4-06052023_040621.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000141588923009236/form4-06052023_040621.xml","form_type":"4"}},{"id":1866069,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":38135,"kind":"person","name":"Reeve Emma","position":1,"cik":"0001680329","reported_name":"Reeve Emma","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-05T20:30:40.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 1, 2023 and is scheduled to vest in full on June 1, 2024."}],"balance_after":25000,"derivative":{"exercise_price":9.55,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-23-009237","document":"form4-06052023_040625.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000141588923009237/form4-06052023_040625.xml","form_type":"4"}},{"id":1866885,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":50572,"kind":"person","name":"Vaishnaw Akshay","position":1,"cik":"0001458494","reported_name":"Vaishnaw Akshay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-05T20:30:32.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 1, 2023 and is scheduled to vest in full on June 1, 2024."}],"balance_after":25000,"derivative":{"exercise_price":9.55,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-23-009234","document":"form4-06052023_040619.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458494/000141588923009234/form4-06052023_040619.xml","form_type":"4"}},{"id":1866148,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":36225,"kind":"person","name":"Hirsch Andrew","position":1,"cik":"0001586707","reported_name":"Hirsch Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-05T20:30:27.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 1, 2023 and is scheduled to vest in full on June 1, 2024."}],"balance_after":25000,"derivative":{"exercise_price":9.55,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-23-009231","document":"form4-06052023_040604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586707/000141588923009231/form4-06052023_040604.xml","form_type":"4"}},{"id":1866068,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":35959,"kind":"person","name":"Scadden David","position":1,"cik":"0001707715","reported_name":"Scadden David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-05T20:30:24.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 1, 2023 and is scheduled to vest in full on June 1, 2024."}],"balance_after":25000,"derivative":{"exercise_price":9.55,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-23-009233","document":"form4-06052023_040614.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000141588923009233/form4-06052023_040614.xml","form_type":"4"}},{"id":1866067,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":78493,"kind":"person","name":"Chatterjee Meeta","position":1,"cik":"0001835388","reported_name":"Chatterjee Meeta","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-05T20:30:09.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 1, 2023 and is scheduled to vest in full on June 1, 2024."}],"balance_after":25000,"derivative":{"exercise_price":9.55,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-23-009230","document":"form4-06052023_040602.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000141588923009230/form4-06052023_040602.xml","form_type":"4"}},{"id":1886436,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2023-05-18T21:20:05.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":155800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on May 17, 2023 and is scheduled to vest over four years, with 25% of the shares to vest on May 17, 2024 and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through May 17, 2027."}],"balance_after":155800,"derivative":{"exercise_price":9.61,"expiration_date":"2033-05-16","underlying":"Common Stock","underlying_shares":155800},"source":{"system":"sec-edgar","filing":"0001415889-23-008293","document":"form4-05182023_090554.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000141588923008293/form4-05182023_090554.xml","form_type":"4"}}],"next_cursor":"2023-05-18T21:20:05.000000Z,1886436"}